Intubation in Coronavirus Disease 19 With Level 3 PPE

Sponsor
Indonesia University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05108584
Collaborator
(none)
39
1
3
2.7
14.3

Study Details

Study Description

Brief Summary

The World Health Organization (WHO) declared COVID-19 as a pandemic in April 2020. COVID-19 first discovered in Wuhan, China in December 2019. As of May 4th, 2020, the total number of patients in China was 82,880, the number of deaths was 4,633, the death rate was 3.7%. In Indonesia, until May 4th 2020, there were 11,192 confirmed cases of COVID-19 with a total of 845 deaths. High transmission and death due to the severe acute respiratory syndrome coronavirus 2, patients with respiratory failure symptoms were suspected of having COVID-19 until declared negative. A potential and continuing threatening complication is acute respiratory failure. Patient with Acute Respiratory Distress Syndrome (ARDS) require both respiratory support and oxygen therapy. The choosing of endotracheal intubation is generally indicated in moderate to severe ARDS. Apart from respiratory failure, endotracheal intubation is also commonly performed in patients undergoing surgical procedures under general anesthesia for the management of the patient's airway. To prevent transmission to medical personnel, intubation is carried out using PPE according to the guidelines. Guidance for intubation in COVID-19 patients is recommended to use a video laryngoscope because it offers several advantages such as assisting glottis visualization and making the intubation operator more distant from the patient's mouth when compared to direct laryngoscopes. This study aims to see the effect of using PPE and the type of laryngoscope on the intubation process carried out in the COVID-19 pandemic. This study is a preliminary study aimed at seeing the effect size of the recommended PPE use on the process and success of intubation.

Condition or Disease Intervention/Treatment Phase
  • Procedure: PPE Level 3 and Video Laryngoscope
  • Procedure: PPE Level 3 and Direct Laryngoscope
  • Procedure: PPE Level 2 and Direct Laryngoscope
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
39 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
The Intubation Procedure in COVID-19 Pandemic
Actual Study Start Date :
Nov 19, 2021
Anticipated Primary Completion Date :
Jan 4, 2022
Anticipated Study Completion Date :
Feb 10, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Group 1 - Level 3 PPE and video laryngoscope

Pre-anesthesia visit aims to assess the participant's physical status based on the American Society of Anesthesiologists score and assessment of the airway. Researcher then explained about the study and plan for anesthesia using an endotracheal tube and personal protective equipment according to the group. While in the operating room, the intubation operator was assisted by an assistant who already used appropriate PPE. Coveralls or hazmat suits and surgical gowns used must match the size. The intubation operator was resident of Anesthesiology and Intensive Therapy study program (stage II) and accompanied by an independent resident (stage III) and an anesthesiologist on duty. The operator used level 3 PPE (coverall jumpsuit, face shield, goggles, N95 mask, surgical mask, boot, scrub, and two layered gloves) and video laryngoscope for intubation of the participants. Researcher was in charge for recording time and event during the intubation process according to the study form.

Procedure: PPE Level 3 and Video Laryngoscope
The operator used level 3 PPE and video laryngoscope for the intubation process

Experimental: Group 2 - Level 3 PPE and direct laryngoscope

Pre-anesthesia visit aims to assess the participant's physical status based on the American Society of Anesthesiologists score and assessment of the airway. Researcher then explained about the study and plan for anesthesia using an endotracheal tube and personal protective equipment according to the group. While in the operating room, the intubation operator was assisted by an assistant who already used appropriate PPE. Coveralls or hazmat suits and surgical gowns used must match the size. The intubation operator was resident of Anesthesiology and Intensive Therapy study program (stage II) and accompanied by an independent resident (stage III) and an anesthesiologist on duty. The operator used level 3 PPE (coverall jumpsuit, face shield, goggles, N95 mask, surgical mask, boot, scrub, and two layered gloves) and direct laryngoscope for intubation of the participants. Researcher was in charge for recording time and event during the intubation process according to the study form.

Procedure: PPE Level 3 and Direct Laryngoscope
The operator used level 3 PPE and direct laryngoscope for the intubation process

Experimental: Group 3 - Level 2 PPE and direct laryngoscope

Pre-anesthesia visit aims to assess the participant's physical status based on the American Society of Anesthesiologists score and assessment of the airway. Researcher then explained about the study and plan for anesthesia using an endotracheal tube and personal protective equipment according to the group. While in the operating room, the intubation operator was assisted by an assistant who already used appropriate PPE. Coveralls or hazmat suits and surgical gowns used must match the size. The intubation operator was resident of Anesthesiology and Intensive Therapy study program (stage II) and accompanied by an independent resident (stage III) and an anesthesiologist on duty. The operator used level 2 PPE (surgical gown/apron, face shield, goggles, N95 mask, surgical mask, boot, scrub, and two layered gloves) and video laryngoscope for intubation of the participants. Researcher was in charge for recording time and event during the intubation process according to the study form.

Procedure: PPE Level 2 and Direct Laryngoscope
The operator used level 2 PPE and direct laryngoscope for the intubation process

Outcome Measures

Primary Outcome Measures

  1. Total duration of the intubation process [During the procedure]

    The sum amount of time needed to complete an intubation process that includes preoxygenation duration, neuromuscular blocker action, laryngoscopy duration, and endotracheal tube position confirmation with ultrasound

  2. Success of intubation process as assessed by number of trials [During the procedure]

    The sum amount of trials needed to successfully place an endotracheal tube to the respiratory system

  3. Safety as assessed by number of participants experiencing complications [During the procedure]

    Number of participants who experience desaturation of oxygen (below 95%), airway injury, increased blood pressure (over 120/80 mmHg)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 59 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age 18 to 59 years old

  • Undergo elective or emergency surgery using general anesthesia with endotracheal tube

  • BMI below 30 kg/m2

Exclusion Criteria:
  • Airway difficulty as assessed by preoperative assessment

  • Critical patients with unstable hemodynamics

  • Suspected or confirmed COVID-19 with ASA 3-5

Contacts and Locations

Locations

Site City State Country Postal Code
1 Cipto Mangunkusumo Hospital Jakarta Pusat DKI Jakarta Indonesia 10430

Sponsors and Collaborators

  • Indonesia University

Investigators

  • Principal Investigator: Dita Aditianingsih, Indonesia University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Dita Aditianingsih, MD, PhD, Anesthesiologist Consultant, Indonesia University
ClinicalTrials.gov Identifier:
NCT05108584
Other Study ID Numbers:
  • IndonesiaU120
First Posted:
Nov 5, 2021
Last Update Posted:
Dec 1, 2021
Last Verified:
Nov 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by Dita Aditianingsih, MD, PhD, Anesthesiologist Consultant, Indonesia University

Study Results

No Results Posted as of Dec 1, 2021